References
- Penzias AS. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online 2004;9:43–6
- Killick S. Ultrasound and the receptivity of the endometrium. Reprod Biomed Online 2007; 15:63–7
- Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod 2006;21:3036–43
- Urman B, Yakin K, Balaban B. Recurrent implantation failure in assisted reproduction: how to counsel and manage: B. Treatment options that have not been proven to benefit the couple. Reprod Biomed Online 2005;11:382–91
- Orvieto R, Meltcer S, Liberty G, et al. A combined approach to patients with repeated IVF failures. Fertil Steril 2010;94:2462–4
- Shapiro BS, Daneshmand ST, Garner FC, et al. Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer. Fertil Steril 2014;102:3–9
- Shapiro BS, Daneshmand ST, Garner FC, et al. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril 2011;96:344–8
- Orvieto R, Fisch B, Feldberg D. Endometrial preparation for patients undergoing frozen-thawed embryo transfer cycles. In: Allahbadia G, Basuray R, Merchant R, eds. The art & science of assisted reproductive techniques. New Delhi, India: Jaypee Brothers Medical Publishers (P) Ltd.; 2003:396–9
- Fatemi HM, Kyrou D, Bourgain C, et al. Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril 2010;94:2054–8
- Tesarik J, Hazout A, Mendoza C. Enhancement of embryo development potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod 2004;19:1176–80
- Tesarik J, Hazout A, Mendoza C, Tesarik R, et al. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist and antagonist-treated ovarian stimulation cycles. Hum Reprod 2006;21:2572–9
- Orvieto R, Laufer N. Ultrashort flare GnRH-agonist/GnRH-antagonist protocol: a valuable tool in the armamentarium of ovulation induction for IVF. Fertil Steril 2014;102:1554–5
- Haas J, Zilberberg E, Dar S, et al. Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles – a preliminary report. J Ovarian Res 2014;7:77
- Zilberberg E, Haas J, Dar S, et al. Co-administration of GnRH-agonist and hCG for final oocyte maturation in patients with low proportion of mature oocytes. Gyn Endocrinol 2014 Nov 11:1–3. [Epub ahead of print] PMID: 25385007
- Simón C, Bellver J. Scratching beneath ‘The Scratching Case': systematic reviews and meta-analyses, the back door for evidence-based medicine. Hum Reprod 2014;29:1618–21
- Morley LC, Simpson N, Tang T. Human chorionic gonadotrophin (hCG) for preventing miscarriage. Cochrane Database Syst Rev 2013 Jan 31 (1); Article ID:CD008611